State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET
18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from 18F-FDG-PET allowed the development of a wide range of PET quantitative analy...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmed.2015.00018/full |
id |
doaj-2fa5e5a58c254220b22ac4c810078213 |
---|---|
record_format |
Article |
spelling |
doaj-2fa5e5a58c254220b22ac4c8100782132020-11-24T23:25:29ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2015-03-01210.3389/fmed.2015.00018126051State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PETThomas eCarlier0Clément eBailly1University hospital of NantesUniversity hospital of Nantes18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from 18F-FDG-PET allowed the development of a wide range of PET quantitative analysis techniques ranging from simple semi-quantitative methods like the standardised uptake value (SUV) to high order metrics that require a segmentation step and additional image processing. In this review, these methods are discussed, focusing particularly on the available methodologies that can be used in clinical trials as well as their current applications in international consensus for PET interpretation in lymphoma and solid tumors.http://journal.frontiersin.org/Journal/10.3389/fmed.2015.00018/fullNuclear MedicinePETfollow-uponcologyquantification |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Thomas eCarlier Clément eBailly |
spellingShingle |
Thomas eCarlier Clément eBailly State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET Frontiers in Medicine Nuclear Medicine PET follow-up oncology quantification |
author_facet |
Thomas eCarlier Clément eBailly |
author_sort |
Thomas eCarlier |
title |
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET |
title_short |
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET |
title_full |
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET |
title_fullStr |
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET |
title_full_unstemmed |
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET |
title_sort |
state-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using pet |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2015-03-01 |
description |
18F-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from 18F-FDG-PET allowed the development of a wide range of PET quantitative analysis techniques ranging from simple semi-quantitative methods like the standardised uptake value (SUV) to high order metrics that require a segmentation step and additional image processing. In this review, these methods are discussed, focusing particularly on the available methodologies that can be used in clinical trials as well as their current applications in international consensus for PET interpretation in lymphoma and solid tumors. |
topic |
Nuclear Medicine PET follow-up oncology quantification |
url |
http://journal.frontiersin.org/Journal/10.3389/fmed.2015.00018/full |
work_keys_str_mv |
AT thomasecarlier stateoftheartandrecentadvancesinquantificationfortherapeuticfollowupinoncologyusingpet AT clementebailly stateoftheartandrecentadvancesinquantificationfortherapeuticfollowupinoncologyusingpet |
_version_ |
1725557234829623296 |